← Open Payments lookup

SARA VANLANINGHAM: Open Payments

NPI 1013469659 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$297 in 16 payments from 11 companies in 2025. Trend: 2023 $259 · 2024 $436 · 2025 $297

Food & beverage: $297
CompanyPaymentsAmount
Novo Nordisk Inc4$68
ABBVIE INC.2$46
Bayer Healthcare Pharmaceuticals Inc.2$41
Dexcom, Inc.1$22
Astellas Pharma US Inc1$21
Otsuka America Pharmaceutical, Inc.1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Lilly USA, LLC1$18
Exact Sciences Corporation1$17
Antares Pharma, Inc.1$14

Products named: QULIPTA, Kerendia, Ozempic, Wegovy, Dexcom G6 Transmitter, Veozah, REXULTI, CAPLYTA.

Industry payments across IN — which companies pay providers there.